The U.S. Food and Drug Administration has recently approved the FreeStyle Libre Flash Glucose Monitoring System, the very first continuous glucose monitoring system that does not require a blood sample from the fingertip.
The patients will have a small wire implanted underneath their skin which will give them continuous access to their glucose levels via a mobile reader. This development in technology could have a very positive effect on how patients manage the disease.
Read the full article below:
To learn more about the FreeStyle Libre, please click below to visit their website: